Filing Flows › Caris Life Sciences (CAI) › Operating margin
Caris Life Sciences (CAI) operating margin by quarter
Caris Life Sciences' operating margin was 7.0% in Q3 2026 (third quarter 2026), -23.2 pts from Q4 2025. Over the last 3 quarters it ranged from 7.0% (Q3 2026) to 30.2% (Q4 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 7.0% | -23.2 pts | -8.0 pts |
| Q4 2025 | 30.2% | +15.1 pts | — |
| Q3 2025 | 15.1% | — | — |
Q3 2026 at a glance
Caris Life Sciences, Q3 2026: revenue $275M (+27% year over year), operating margin 7.0%, net earnings $15.2M, operating cash flow −$22.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Caris Life Sciences' operating margin?
Caris Life Sciences' operating margin was 7.0% in Q3 2026 (third quarter 2026), -23.2 pts from Q4 2025.
How has Caris Life Sciences' operating margin changed?
Over the last 3 quarters it ranged from 7.0% (Q3 2026) to 30.2% (Q4 2025).